Market Overview:
The global microbial antimicrobial peptides market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for antibiotics and rising awareness about the benefits of using microbial antimicrobial peptides over traditional antibiotics. In addition, the growing demand for feed additives is also contributing to the growth of this market. Based on type, bacteria are expected to account for a larger share of the global microbial antimicrobial peptides market in 2018. This can be attributed to their high efficacy against various types of bacteria and their ability to reduce inflammation caused by these microorganisms.
Product Definition:
Microbial Antimicrobial peptides are proteins that are produced by certain types of microbes to help them defend themselves against other microbes. These peptides can kill or inhibit the growth of other microbes, making them useful for treating infections.
Bacteria:
Bacteria is a single-celled organism which lives in the soil, water or air and can be used for industrial as well as medical purpose. Bacteria can be categorized on the basis of their size, shape and ability to grow. Some bacteria such as Proteus mirabilis have the ability to infect human beings causing urinary tract infections (UTIs) while some are useful for producing antibiotics.
Fungi:
Fungi is a eukaryotic or multicellular organisms that reproduce by means of spores. The word fungible may be used interchangeably with the term fungi, but technically refers to the group of all microorganisms that lack chlorophyll and are unable to photosynthesize. Fungi include molds, rusts, mildews, mushrooms; yeasts are single-celled fungi; and mushrooms are also known as mycelium.
Application Insights:
The global market is segmented by application into pharmaceuticals, feed additives and others. The other applications include textiles, food and beverages, environment (water treatment), skin care products among others. Feed additives segment held the largest share in 2017 owing to extensive usage of antimicrobial peptides for improving animal health & productivity as well as animal comfort.
In addition to this they are also used for preventing diseases such as diarrhea and pneumonia in animals that consume contaminated feeds. Furthermore these compounds have a huge potential in the field of agriculture due to their ability to control soil microbes including bacteria and fungi which cause infections in plants roots leading to reduced plant growth & development resulting into lower crop yield which ultimately reduces profit margin for farmers thus promoting efficiency over quantity when it comes to using these products on an agricultural scale thus further boosting its demand globally.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing demand for animal feed additives and growing pharmaceutical industry. In addition, countries such as China and India are experiencing a high growth rate in food & beverage sector which will drive product demand over the next eight years.
Europe is also estimated to be one of the promising regional markets with major countries, such as Germany, France and Italy contributing significantly towards industry growth due to rising product consumption in various end-use industries including cosmetics & personal care products, pharmaceuticals etc. Moreover, presence of stringent regulations by agencies like EMEA regarding use of antimicrobial peptides (AMPs) for human consumption will further boost regional market development over the forecast period.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the microbial antimicrobial peptides market. Microbial antimicrobial peptides are effective in treating a wide range of infections caused by bacteria, viruses, and other pathogens.
- Growing demand for novel antibiotics: The growing demand for novel antibiotics is another key factor driving the microbial antimicrobial peptides market. Microbial antimicrobial peptides offer an alternative to conventional antibiotics and are effective against drug-resistant pathogens.
- Rising awareness about benefits of microbial antimicrobial peptides: There is a growing awareness about the benefits of microbial antimicrobial peptides among healthcare professionals and consumers alike. This is helping to drive demand for these products worldwide.
- Technological advancements in production processes: Technological advancements in production processes have helped to reduce manufacturing costs and improve product quality, thus boosting sales growth prospects for the microbial antimicrobial peptide market globally . 5) Growing investments by pharmaceutical companies: Pharmaceutical companies are increasingly investing in research and development activities aimed at discovering new microbicidal agents that can be used as therapeutics or prophylactics against antibiotic-resistant infections
Scope Of The Report
Report Attributes
Report Details
Report Title
Microbial Antimicrobial Peptides Market Research Report
By Type
Bacteria, Fungi
By Application
Pharmaceuticals, Feed Additives, Others
By Companies
AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, AnaSpec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Microbial Antimicrobial Peptides Market Report Segments:
The global Microbial Antimicrobial Peptides market is segmented on the basis of:
Types
Bacteria, Fungi
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals, Feed Additives, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AnaSpec
- AMP Biotech
- Phoenix Biotech
- Novabiotics
- Chinese Peptide
- Ontores
- AnaSpec
Highlights of The Microbial Antimicrobial Peptides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bacteria
- Fungi
- By Application:
- Pharmaceuticals
- Feed Additives
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microbial Antimicrobial Peptides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microbial antimicrobial peptides (MAPs) are short peptides that are produced by some bacteria and fungi. MAPs have been shown to kill or inhibit the growth of many types of microbes, including bacteria, viruses, and fungi.
Some of the major players in the microbial antimicrobial peptides market are AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, AnaSpec.
The microbial antimicrobial peptides market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microbial Antimicrobial Peptides Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microbial Antimicrobial Peptides Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microbial Antimicrobial Peptides Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microbial Antimicrobial Peptides Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microbial Antimicrobial Peptides Market Size & Forecast, 2018-2028
4.5.1 Microbial Antimicrobial Peptides Market Size and Y-o-Y Growth
4.5.2 Microbial Antimicrobial Peptides Market Absolute $ Opportunity
Chapter 5 Global Microbial Antimicrobial Peptides Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Microbial Antimicrobial Peptides Market Size Forecast by Type
5.2.1 Bacteria
5.2.2 Fungi
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Microbial Antimicrobial Peptides Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Microbial Antimicrobial Peptides Market Size Forecast by Applications
6.2.1 Pharmaceuticals
6.2.2 Feed Additives
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microbial Antimicrobial Peptides Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microbial Antimicrobial Peptides Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Microbial Antimicrobial Peptides Analysis and Forecast
9.1 Introduction
9.2 North America Microbial Antimicrobial Peptides Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Microbial Antimicrobial Peptides Market Size Forecast by Type
9.6.1 Bacteria
9.6.2 Fungi
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Microbial Antimicrobial Peptides Market Size Forecast by Applications
9.10.1 Pharmaceuticals
9.10.2 Feed Additives
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Microbial Antimicrobial Peptides Analysis and Forecast
10.1 Introduction
10.2 Europe Microbial Antimicrobial Peptides Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Microbial Antimicrobial Peptides Market Size Forecast by Type
10.6.1 Bacteria
10.6.2 Fungi
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Microbial Antimicrobial Peptides Market Size Forecast by Applications
10.10.1 Pharmaceuticals
10.10.2 Feed Additives
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Microbial Antimicrobial Peptides Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Microbial Antimicrobial Peptides Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Microbial Antimicrobial Peptides Market Size Forecast by Type
11.6.1 Bacteria
11.6.2 Fungi
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Microbial Antimicrobial Peptides Market Size Forecast by Applications
11.10.1 Pharmaceuticals
11.10.2 Feed Additives
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Microbial Antimicrobial Peptides Analysis and Forecast
12.1 Introduction
12.2 Latin America Microbial Antimicrobial Peptides Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Microbial Antimicrobial Peptides Market Size Forecast by Type
12.6.1 Bacteria
12.6.2 Fungi
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Microbial Antimicrobial Peptides Market Size Forecast by Applications
12.10.1 Pharmaceuticals
12.10.2 Feed Additives
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Microbial Antimicrobial Peptides Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Microbial Antimicrobial Peptides Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Microbial Antimicrobial Peptides Market Size Forecast by Type
13.6.1 Bacteria
13.6.2 Fungi
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Microbial Antimicrobial Peptides Market Size Forecast by Applications
13.10.1 Pharmaceuticals
13.10.2 Feed Additives
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microbial Antimicrobial Peptides Market: Competitive Dashboard
14.2 Global Microbial Antimicrobial Peptides Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AnaSpec
14.3.2 AMP Biotech
14.3.3 Phoenix Biotech
14.3.4 Novabiotics
14.3.5 Chinese Peptide
14.3.6 Ontores
14.3.7 AnaSpec
